Time-varying effects of prognostic factors associated with long-term survival in breast cancer

Endocrine-related Cancer
Minlu ZhangPingping Bao

Abstract

The impact of some prognostic factors on breast cancer survival has been shown to vary with time since diagnosis. However, this phenomenon has not been evaluated in Asians. In the present study, 4886 patients were recruited from the Shanghai Breast Cancer Survival Study, a longitudinal study of patients diagnosed during 2002-2006, with a median follow-up time of 11.2 years. Cox model incorporating time-by-covariate interactions was used to describe the time-varying effects of prognostic factors related to overall survival and disease-free survival. Age ≥65 years showed a progressively negative effect on breast cancer prognosis over time, whereas tumour size >2 cm had a lasting and constant impact. Age significantly modified the effects of the tumour grade, nodal status and oestrogen receptor (ER) status on breast cancer survival. The detrimental effect of poorly differentiated tumours was time limited and more obvious in patients aged 45-54 years. Having ≥4 positive lymph nodes had a persistent and negative impact on prognosis, although it attenuated in later years; the phenomenon was more prominent in the 55-64-year age group. ER-positive status was protective in the first 3 years after diagnosis but was related to a higher ri...Continue Reading

References

Sep 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P P RosenD W Kinne
Jul 9, 1994·BMJ : British Medical Journal·H W NabJ W Coebergh
Jul 3, 1993·Lancet·M T O'Rourke, P T Ellison
Jul 15, 1997·Statistics in Medicine·P H Zahl, S Tretli
Jan 9, 1998·Computer Methods and Programs in Biomedicine·H Heinzl, A Kaider
Mar 5, 1999·Breast Cancer Research and Treatment·S G HilsenbeckG M Clark
Jun 13, 2001·Journal of the American College of Surgeons·C GajdosJ L Bernstein
Jun 21, 2001·Environmental Science & Technology·I EideO Kvalheim
Mar 4, 2003·Breast Cancer Research and Treatment·Kenneth R HessGabriel N Hortobagyi
Aug 13, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine BouchardyGeorges Vlastos
Dec 24, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hermann Brenner, Timo Hakulinen
May 11, 2006·Breast Cancer Research and Treatment·William F AndersonPhilip S Rosenberg
May 23, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sei Hyun AhnUNKNOWN Korean Breast Cancer Society
Jul 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anna Marie MulliganIrene L Andrulis
Aug 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Simone Mathoulin-PelissierAndrew Kramar
Oct 3, 2008·Breast Cancer Research and Treatment·James J DignamNorman Wolmark
Oct 22, 2008·Breast Cancer Research and Treatment·C CluzeN Bossard
May 1, 2009·American Journal of Epidemiology·Loki NatarajanJohn P Pierce
May 26, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L M WoodsM P Coleman
Dec 10, 2009·JAMA : the Journal of the American Medical Association·Xiao Ou ShuWei Lu
Mar 24, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mara A SchonbergEllen P McCarthy
Dec 21, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Katie M O'BrienRobert C Millikan
May 11, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ismail JatoiCarol K Redmond
Sep 14, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edoardo ColzaniKamila Czene
Feb 22, 2012·Perspectives in Clinical Research·Priya Ranganathan, C S Pramesh

❮ Previous
Next ❯

Citations

Mar 11, 2020·Cancer Medicine·Carlo BoeriFrancesca Rovera
Oct 8, 2020·Nature Reviews. Cancer·Christoph A Klein
Mar 29, 2021·The Breast : Official Journal of the European Society of Mastology·Fei PengYu Hu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie
A S AlbertsR van der Merwe
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Yousif O Al-BazzPauline R M Dobson
© 2022 Meta ULC. All rights reserved